Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
Will someone tell this author to do his homework and stop pumping Ariad Pharma. This stock is not a stem-cell stock, but merely a company with a history of massive losses from a CEO who was runner up for "Worst Biotech CEO of 2008."
Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
12 Stem Cell Stocks - Updated [View article]
12 Stem Cell Stocks - Updated [View article]
Sounds to me like a pump-job trying to get the shares to artificially inflate on a pump and dumper.